EZH2 and breast carcinoma: As an oncogene, growing evidence has identified EZH2 was closely related to breast cancer development and progression through multiple molecular mechanisms35,36, but no studies are related to the roles of CENPL, ISG20L2, MRPL3 and LSM4 in breast cancer.